These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 3453383)
1. Malignant arterial hypertension. Relationship between blood pressure control and renal function during long-term observation of patients with malignant nephrosclerosis. Jespersen B; Eiskjaer H; Christiansen NO; Olsen S; Pedersen EB J Clin Hypertens; 1987 Dec; 3(4):409-18. PubMed ID: 3453383 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722 [TBL] [Abstract][Full Text] [Related]
3. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease. Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104 [TBL] [Abstract][Full Text] [Related]
4. Discontinuation of chronic haemodialysis after control of arterial hypertension; long term follow-up. Wauters JP; Brunner HR Proc Eur Dial Transplant Assoc; 1983; 19():182-7. PubMed ID: 6878232 [TBL] [Abstract][Full Text] [Related]
6. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642 [TBL] [Abstract][Full Text] [Related]
7. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study. Siewert-Delle A Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677 [TBL] [Abstract][Full Text] [Related]
8. The short-term course of renal function in malignant hypertensives with renal insufficiency. Lawton WJ Clin Nephrol; 1982 Jun; 17(6):277-83. PubMed ID: 7105502 [TBL] [Abstract][Full Text] [Related]
9. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T; Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [TBL] [Abstract][Full Text] [Related]
10. Renal vascular lesions in severe hypertension. Transitional changes from benign to malignant nephrosclerosis. Akikusa B; Kondo Y; Irabu N; Shigematsu H Acta Pathol Jpn; 1983 Mar; 33(2):323-31. PubMed ID: 6869004 [TBL] [Abstract][Full Text] [Related]
11. [Course of renal function in malignant hypertension. Effect of treatment. Study of 30 cases followed for 5 to 18 years]. Laville M; Arkouche W; Pozet N; Hadj-Aissa A; Labeeuw M; Zech P Arch Mal Coeur Vaiss; 1986 Jun; 79(6):767-72. PubMed ID: 3099691 [TBL] [Abstract][Full Text] [Related]
12. Continuing follow-up of malignant hypertension. Scarpelli PT; Gallo M; De Cesaris F; Chiari G; Dedola G; Cappeli S; Becucci A; Becherelli P; Tosi B; Fanetti C; Fanelli R J Nephrol; 2002; 15(4):431-7. PubMed ID: 12243376 [TBL] [Abstract][Full Text] [Related]
13. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Estacio RO; Jeffers BW; Gifford N; Schrier RW Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192 [TBL] [Abstract][Full Text] [Related]
15. [Peracute primary malignant nephrosclerosis with irreversible kidney failure and malignant hypertension following ovulation inhibitors]. Bock KD; Bohle A Dtsch Med Wochenschr; 1973 Apr; 98(15):757-61. PubMed ID: 4121156 [TBL] [Abstract][Full Text] [Related]
16. [Effect of hypertension on function of the transplanted kidney--3 years follow-up]. Oko A; Olejnik A; Idasiak-Piechocka I; Włodarczyk Z; Głyda M; Czekalski S Przegl Lek; 2003; 60(11):686-9. PubMed ID: 15058033 [TBL] [Abstract][Full Text] [Related]
17. [The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis]. Rodríguez Pérez JC; Maynar Moliner M; Pérez Borges P; Plaza Toledano C; Reyes Pérez R; Pulido Duque JM; Palop Cubillo L; Rodríguez Pérez A Med Clin (Barc); 1997 Mar; 108(10):366-72. PubMed ID: 9139142 [TBL] [Abstract][Full Text] [Related]
18. Sustained beneficial effects on blood pressure during long time retrospective follow-up after endovascular treatment of renal artery occlusion. Alhadad A; Mattiasson I; Ivancev K; Gottsäter A; Lindblad B J Hum Hypertens; 2004 Oct; 18(10):739-44. PubMed ID: 15085169 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure and renal outcomes in patients with kidney infarction and hypertension. Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969 [TBL] [Abstract][Full Text] [Related]
20. Synthetic/secreting and apoptotic phenotypes in renal biopsy tissues from hypertensive nephrosclerosis patients. Kimura N; Yonemoto S; Machiguchi T; Li X; Kimura H; Yoshida H Hypertens Res; 2006 Aug; 29(8):573-80. PubMed ID: 17137212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]